Spondyloarthritis

Incident Hypertension Associated With Continuous NSAID Use in Ankylosing Spondylitis

Researchers investigated the association of NSAID use with the development of incident hypertension in a cohort of patients with ankylosing spondylitis.

Increased Risk for Certain Inflammatory Diseases With Newly Diagnosed Ankylosing Spondylitis

Researchers investigated the risk for immune-mediated inflammatory diseases in patients with ankylosing spondylitis.

Reduced Mobility From Bone Bridge Formation Affects Low BMD in Ankylosing Spondylitis

Researchers conducted this study to determine whether bone bridge formation was correlated with low bone mineral density in patients with ankylosing spondylitis.

Ankylosing Spondylitis Linked With High Prevalence of Depression

This study aimed to provide an estimate of depression prevalence among patients with ankylosing spondylitis vs those without ankylosing spondylitis.

ASAS Working Group Updates Definitions of MRI Lesions in Sacroiliac Joints With SpA

The ASAS MRI working group created a consensus update on standardized definitions for MRI lesions in the sacroiliac joint of patients with spondyloarthritis and to perform preliminary validation.

First-Time Initiation of TNFi Therapy Shows Positive Disease Outcomes in Axial Spondyloarthritis

Investigators reviewed drug retention and response rates in patients with axial spondyloarthritis after their first initiation with tumor necrosis factor inhibitors.

Updated 2019 ACR Recommendations for Treatment of Ankylosing Spondylitis, Nonradiographic Axial SpA

Based on new evidence and an expert consensus, the American College of Rheumatology (ACR), the Spondylitis Association of America, and the Spondyloarthritis Research and Treatment Network released updated recommendations for the treatment of axial spondyloarthritis (SpA), which comprises ankylosing spondylitis (AS) and nonradiographic axial SpA. This report was published in Arthritis Care & Research. A systematic…

HLA Alleles With Risk for Ankylosing Spondylitis, Rheumatoid Arthritis Affect Gut Microbiome

Researchers examined the effects of HLA-B27 and HLA-DRB1 alleles on the intestinal microbiome of healthy individuals.

Treatment Guidelines Updated for Ankylosing Spondylitis, Axial SpA

Updated recommendations for the treatment of ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis were presented.

Ixekizumab Gains FDA Approval for Treatment of Active Ankylosing Spondylitis

The FDA has approved Taltz (ixekizumab; Eli Lilly) for the treatment of adults with active ankylosing spondylitis (AS), also known as radiographic axial spondyloarthritis.